Botulinum toxin in closed treatment of mandibular condylar fracture.
BACKGROUND
The topic of condylar injury in adults has generated more discussion and controversy than any other in the field of maxillofacial trauma. The treatment of condylar fractures in adults is still a highly debated theme.


METHODS
Patients with unilateral subcondylar or condylar neck fractures of the mandibula without any significant angulation of the condylar head were managed with closed-treatment protocol. Closed treatment was applied through the injection of 100 units of botulinum toxin A, diluted to a concentration of 20 IU/mL, into the muscles of mastication of the fractured side. Masseter and anterior fibers of temporalis muscles were reached through percutaneous extraoral route and 30 IU of the toxin was injected to each muscle. Additional 40 IU of the toxin was injected around the fractured bone fragments through transmucosal intraoral route to paralyze medial and lateral pterygoid muscles as much as possible. An asymmetric occlusal splint was applied for maxillomandibular fixation to restore the vertical height for 10 days. Functional therapy with intermaxillary guiding elastics was advocated for 2 months.


RESULTS
There were no complications related to either toxin injections or splint application procedures. The toxin was effective on all occasions. Fractured condylar process and ramus of the mandibula were in good approximation and remained in reduced positions. None of the patients had any occlusal disturbance, mandibular asymmetry, or joint dysfunction in the follow-up period.


CONCLUSIONS
We believe that modification of treatment options concerning the clinical situation of the patients is the best method for condylar injury. The purpose of this study is to present and discuss the results achieved in closed treatment of a selected group of patients with mandibular condylar fractures to whom botulinum toxin A was injected to relieve the spasm of muscles of mastication, along with special splint application.
Canter
Halil Ibrahim
HI
Hacettepe University, Faculty of Medicine, Department of Plastic and Reconstructive Surgery, Ankara, Turkey. hicanter@gmail.com
Kayikcioglu
Aycan
A
Aksu
Muge
M
Mavili
Mehmet Emin
ME
D000293:Adolescent; D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005592:Fracture Fixation / Q000379:methods*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008335:Mandibular Condyle / Q000000981:diagnostic imaging / Q000293:injuries*; D008337:Mandibular Fractures / Q000000981:diagnostic imaging / Q000628:therapy*; D008410:Masticatory Muscles; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013165:Splints; D014057:Tomography, X-Ray Computed
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A